Available: Accessed November 18, 2024.
The FDA biomarker qualification program (reviewed in 319 ) sets the path for analytes to be considered drug development tools
It is unique because it is a dual-agonist of two important hormones: GLP-1 (Glucagon-like peptide-1): Similar to medications like semaglutide, it mimics this hormone, which helps regulate blood sugar levels by increasing insulin secretion and reducing the amount of glucose produced by the liver
If you want to know whether you may be a candidate for treatment, you can take the free assessment quiz
PRO-C3 290 , produced by fibroblasts as they deposit collagen type III, predicts fibrosis progression 153 , reflects fibrosis stage 291 , and can predict future lethal events 292 , disease outcome 293 , and importantly, monitors disease activity during and after therapeutic intervention 154 across cohorts subject to different diseases or treatments